Letters to the Editor

Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed CBFβ::MYH11+ acute myeloid leukemia

National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
Department of Hematology, The Second People's Hospital of Huai'an, Huai'an
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou
National Clinical Research Center for Hematologic Diseases, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou
Haematologica Early view Feb 20, 2025 https://doi.org/10.3324/haematol.2024.286836